Gain a Chromosome and Adapt

Research in yeast shows that aneuploidy is both a consequence of and an adaptation to stress.

Medivir: Medivir’s Partner GSK Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo

HUDDINGE, Sweden--(BUSINESSWIRE)-- Regulatory News: Medivir AB (STO:MVIRB), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product ...

Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade Names Zoviduo and Zovirax Duo

HUDDINGE, Sweden, February 8, 2012 /PRNewswire/ --Medivir AB (OMX: MVIR), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product ...

Vt. considers bill to allow marijuana for PTSD

The Associated Press The Associated Press MONTPELIER, Vt. A Vermont lawmaker wants to amend the state's medical marijuana law to allow it to be used to treat people suffering from post-traumatic stress disorder. State Rep. Jim Masland of Thetford says he introduced the bill after he was asked to do so by a number of his constituents who were using marijuana to alleviate stress symptoms caused by ...

Medivir: Medivirs Partner GSK Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo

Regulatory News: Medivir AB (STO:MVIRB), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product ...

Spike in deaths blamed on 2003 New York blackout

(Reuters) - A vast electricity blackout in the United States and Canada in 2003 led to the deaths of nearly 100 people, a study found, linking the deaths -- higher than official estimates -- to not only accidents caused by lack of power, but also underlying diseases. Researchers said the study published in the journal Epidemiology was the first to show that the death toll of such a power outage ...

Press Release

Medivir AB (STO:MVIRB), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear®, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.